Table 1.
Entire Cohort (N = 937) | Cohort on Immunosuppressive Therapy (N = 573) | |||||
---|---|---|---|---|---|---|
CD (N = 427) | UC (N = 510) | Combined | CD (N = 307) | UC (N = 266) | Combined | |
Female, n (%) | 221 (52.8%) | 220 (43.1%) | 441 (47.1%) | 160 (52.1%) | 115 (43.2%) | 275 (48.0%) |
Age (years), median (IQR) | 29.5 (21.2, 46.6) | 35 (24.8, 48) | 32.8 (23.7, 47.4) | 27.9 (20.5, 42.1) | 34.2 (24.2, 48.3) | 30.8 (22.3, 46.0) |
White race | 412 (96.5%) | 487 (95.5%) | 899 (95.9%) | 296 (96.4%) | 259 (97.4%) | 555 (96.9%) |
Follow up (years), median (IQR) | 14.3 (7.9, 24.1) | 15.3 (7.8, 25.8) | 14.8 (7.9, 25) | 14.6 (8.2, 24.7) | 14.4 (8.3, 23.2) | 14.5 (8.3, 23.9) |
CD, Crohn’s disease; UC, Ulcerative colitis; IQR, Interquartile range